In a sign of just how tough the funding environment has become for the biotech industry, Singapore’s Tessa Therapeutics has pulled stumps after failing to raise more capital to advance its next generation cell therapy ambitions.
https://www.fiercebiotech.com/biotech/tessa-therapeutics-dissolves-after-raising-more-200m
https://www.geneonline.com/singapore-tessa-therapeutics-announces-liquidation/
- Forums
- ASX - By Stock
- PTX
- Fair Valuation of PTX
Fair Valuation of PTX, page-267
Featured News
Add PTX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $33.82M |
Open | High | Low | Value | Volume |
4.2¢ | 4.2¢ | 4.2¢ | $17.55K | 418.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 80471 | 4.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.4¢ | 225514 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 80471 | 0.042 |
3 | 1034391 | 0.041 |
9 | 797493 | 0.040 |
5 | 389000 | 0.039 |
2 | 225000 | 0.038 |
Price($) | Vol. | No. |
---|---|---|
0.044 | 225514 | 2 |
0.045 | 831675 | 6 |
0.047 | 525000 | 2 |
0.048 | 58027 | 1 |
0.050 | 310539 | 3 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |